SCHEMBL4943630

SCHEMBL4943630

N=C(N)NC(=O)c1ccc(-c2ccc([N+](=O)[O-])cc2)o1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.62
MEN1 O00255 7/20 0.62
NPC1 O15118 4/20 0.62
MAPT P10636 11/20 0.59
ALDH1A1 P00352 8/20 0.59
POLB P06746 3/20 0.57
THRB P10828 1/20 0.57
LMNA P02545 5/20 0.57
NQO2 P16083 1/20 0.56
ATM Q13315 1/20 0.56
RAB9A P51151 4/20 0.55
GAA P10253 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
MGAM O43451 1/20 0.55
SI P14410 1/20 0.55
STAT1 P42224 1/20 0.55
RECQL P46063 1/20 0.55
MGAM2 Q2M2H8 1/20 0.55
TDP1 Q9NUW8 1/20 0.55
MAPK1 P28482 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4941158 0.85 ALDH1A1 (0.74) KMT2AMEN1NPC1MAPTALDH1A1
SCHEMBL27759320 0.83 MAPT (0.71) KMT2AMEN1NPC1MAPTALDH1A1
SCHEMBL4943698 0.82 LMNA (0.51) KMT2AMEN1MAPTALDH1A1LMNA
SCHEMBL4943738 0.81 SLC9A1 (0.57) KMT2AMEN1NPC1MAPTALDH1A1
SCHEMBL11491771 0.78 MAPT (0.58) KMT2AMEN1NPC1MAPTALDH1A1
SCHEMBL4944763 0.77 MAPKAPK2 (0.52) ALDH1A1LMNANQO2HPGDKDM4E
SCHEMBL1317292 0.77 KMT2A (0.66) KMT2AMEN1NPC1MAPTALDH1A1
SCHEMBL4937803 0.76 ALDH1A1 (0.49) KMT2AMEN1MAPTALDH1A1POLB
SCHEMBL2026125 0.76 MAPT (0.65) KMT2AMEN1NPC1MAPTALDH1A1
Hydrochloric Acid SCHEMBL3452251 0.76 KMT2A (0.64) KMT2AMEN1NPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7351843-B2 Furancarbonylguanidine derivatives, their preparation and pharmaceutical compositions containing them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-04-01 US disclosed
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299131-A1 Furancarbonylguanidine Derivatives, Their Preparation and Pharmaceutical Compositions Containing Them SLC9A1, NHERF1, SLC5A1 KMT2A 4059/4885MEN1 2726/4885NPC1 352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.